Esophageal cancer · 2 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
FOLFOX4 Variant #01 | — | R 2 374 | 14d | ~8.0 mo | ~12.9 mo | ~3 | ~R 7 122 PFS proxy · indirect | 14 |
Cisplatin and Fluorouracil (CF) Variant #01 | — | R 1 235 | 28d | — | ~9.8 mo | ~7 | ~R 8 648 PFS proxy · indirect | 4 |
2 of 2 regimens shown